Fishawack Health appoints new CEO, Jonathan Koch
October 5, 2021 | CEO, Chief Executive Officer, Company news, Corporate announcement, Market Access, Marketing, Medical Communications, biotech, consulting, pharmaceutical
Koch will draw on his exceptional experience leading global, customer-centered organizations of scale to build a sustainable future for Fishawack Health.
October 5, 2021, Knutsford, UK. Fishawack Health announces the appointment of Jonathan (Jon) Koch as its new CEO. Jon will lead the commercialization partner through its next stage of growth, centered on building and retaining talented teams and delivering a full set of integrated services for our clients across the life science industry.
Jon’s appointment follows the announcement of Liz Landon as Chief People Officer, cementing the company’s pledge to build an enviable company culture that makes Fishawack Health an outstanding organization to develop, grow, and thrive.
Jon has a significant track record in transforming businesses and managing large, global, customer-centered organizations. He has spent his entire career in the healthcare sector, including nearly 12 years at Covance (now Labcorp Drug Development), serving last as Group President of Clinical Development and Commercialization services, leading more than 11,000 employees across dozens of countries. Early in his career, Jon developed a deep passion for helping pharmaceutical and biotech clients bring innovative therapies to market that positively affect patients’ outcomes.
Most recently, Jon served as Senior Vice President and CEO of Global Dental at the publicly listed organization Henry Schein, where he was responsible for the strategic direction and business performance of its largest healthcare division and leading technology business.
Jon subscribes to a people-led philosophy and believes in the power of diverse teams. He is practiced in building and developing talented, high-performing teams that deliver exceptional results for the companies and clients they support.
He will usher in a new phase of growth—from Phase 1, “The foundation phase”, to Phase 2, “Building a sustainable future”—for Fishawack Health. The company was founded by Oliver Dennis and Dominic Miller in 2001 and over the last two decades has grown rapidly through organic strategies and the acquisition of 16 companies spanning medical communications, healthcare marketing and consultancy, and value evidence and access.
“I’m incredibly excited to join Fishawack Health,” says Jon. “The organization delivers exceptional work across the product and service lifecycle and has an enviable roster of life science and medical device clients, as well as healthcare startups. I look forward to contributing my knowledge of building dynamic businesses that generate exceptional results for customers, their stakeholders, and our team members.”
He adds, “By further developing the company’s unifying mission, vision, and strategy, and fostering a working environment that encourages and empowers staff, we can support team members as they innovate and do greater things for themselves, our clients, and of course the patients and healthcare professionals we all serve.”
“This is an exciting time for Jon to join our organization,” says Gail Flockhart, Group President. “We have achieved tremendous growth through extensive client relationships, and our acquisition strategy has successfully brought specialist capabilities together to become a leading commercialization partner for clients. We are looking forward to this new phase in which Jon can share his extensive experience of successfully unifying businesses by improving team development, processes, and infrastructure needed for efficient and effective delivery of new integrated services and technologies.”
Jon’s appointment follows the news that Oliver and Dominic stepped down from their roles as CEO and COO in September. The Fishawack Health team greatly respects and appreciates their leadership and personal investment in building the company over the last 20 years and is excited to usher in a new era under Jon’s leadership.
About Fishawack Health
Fishawack Health is the leading global commercialization partner for the modern life science era. Established in 2001 and headquartered in the UK, the organization is powered by a 1,300+ globe-spanning pack of strategic, creative, and scientific experts. Weempower healthcare professionals and patients with the knowledge they need to live better lives.
Our core operating units—Medical, Marketing, Market Access, and Consulting—bring together best-in-class capabilities from around the world. We empower our pharmaceutical, biotech, and medical technology clients to navigate the most complex of ecosystems, helping them on an effective path to develop, launch, and grow their brands, services, and portfolios.
Our internationally recognized, award-winning teams collaborate across operations in the UK (Brighton, Fleet, London, Knutsford, Manchester, Oxford, and Sale), Ireland (Dublin), USA (Chicago, Evansville, Minneapolis, New York, Philadelphia, San Diego, Scottsdale, and St. Louis), Greece (Athens), and Singapore.
Visit us at www.fishawack.com and follow us on Twitter and LinkedIn.
Contact:
UK: Sophie Berger
US: Elizabeth Mitchell
emitchell@closerlook.com
This content was provided by Avalere Health
Company Details
Latest Content from Avalere Health
Avalere Health appoints new President of Medical to lead a tech-enabled future of medical affairs
Avalere Health appoints seasoned industry executive Effie Baoutis as President of Medical.
Fishawack Health becomes Avalere Health, uncovering the potential in every product and the possibilities for every patient
As a single united organization, the company seamlessly connects science and creativity, technology and data, and ability and agility to ensure patients receive life-changing innovations faster.
Industry leader Amar Urhekar joins Fishawack Health as Chief Operating Officer to integrate interdisciplinary teams across capabilities
As Chief Operating Officer, Amar will unite global teams to drive innovation, enhance client solutions, and accelerate growth.
Fishawack Health appoints Chief People Officer to spearhead integration of talent and culture across geographies
Fishawack Health welcomes Harriet Shurville to the team as Chief People Officer to spearhead integration efforts, champion diversity and inclusion, and cultivate an environment where interdisciplinary teams thrive.
Archetypes: Rethinking go-to-market expectations to drive commercial success
In this white paper, our consultants analyze trends spanning global policy developments, rising inflation, and increasingly complex customer journeys, and reveal a new data-driven approach to archetyping that crystalizes the...
Fishawack Health deepens key capabilities and builds an integrated delivery model under new Chief Marketing and Creative Officer
Polymath marketer Ryan Mason leads the newly expanded group, and Jeffrey D. Erb has been tapped to grow the media and analytics team as Chief Media Officer.
Oncology eBook: Reducing the care gap in cancer prevention, diagnosis, and treatment
Despite significant innovation in the oncology landscape, there is a growing care gap preventing patients accessing and benefiting from innovations in cancer treatment. In this new publication, our oncology experts...
The challenges of reimbursement and innovative pricing for cell and gene therapies
Our policy and market access experts at Avalere, part of Fishawack Health, share insights on the reimbursement challenges for cell and gene therapies and discuss the challenges and opportunities of...
Digital therapeutics as a combination therapy: Maximizing asset value and therapeutic outcomes
Digital therapeutics can increase the value of medicinal assets, driving differentiation and improving outcomes for patients. But are manufacturers prepared to capitalize on this significant untapped opportunity before the tech...
Fishawack Health welcomes Mario Muredda as its new President of Marketing
Fishawack Health (FH) ushers in a new era of data-driven omnichannel marketing with the hire of healthcare marketing veteran Mario Muredda.